TCMP
TMO icon

Thrive Capital Management (Pennsylvania)’s Thermo Fisher Scientific TMO Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-385
Closed -$204K – 202
2023
Q4 		$204K Buy
+385
New +$186K 0.11% 149

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Thrive Capital Management (Pennsylvania)'s TMO Position: Q1 2024 in Review

Thrive Capital Management (Pennsylvania) sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 385 shares — an estimated $204K sold.

Thrive Capital Management (Pennsylvania) first reported a position in TMO in Q4 2023 and held it in 1 quarter. The position peaked at $204K in Q4 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Thrive Capital Management (Pennsylvania) reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 385 Thermo Fisher Scientific shares in Q1 2024, an estimated $204K.
  • Thrive Capital Management (Pennsylvania) first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 1 quarter.
  • Thrive Capital Management (Pennsylvania)'s Thermo Fisher Scientific position peaked at $204K in Q4 2023.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2024, filed 13 May 2024.